130 related articles for article (PubMed ID: 29240011)
1. Fecal Calprotectin Test Performed at Home: A Prospective Study of Pediatric Patients With Inflammatory Bowel Disease.
Piekkala M; Alfthan H; Merras-Salmio L; Puustinen Wikström A; Heiskanen K; Jaakkola T; Klemetti P; Färkkilä M; Kolho KL
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):926-931. PubMed ID: 29240011
[TBL] [Abstract][Full Text] [Related]
2. IBDoc Canadian User Performance Evaluation.
Moore AC; Huang VW; Bourdages R; Fedorak RN; Reinhard C; Leung Y; Bressler B; Rosenfeld G
Inflamm Bowel Dis; 2019 May; 25(6):1107-1114. PubMed ID: 30535387
[TBL] [Abstract][Full Text] [Related]
3. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
[TBL] [Abstract][Full Text] [Related]
4. The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease.
Lerchova T; Hradsky O; Copova I; Potuznikova K; Gonsorcikova L; Bronsky J
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):75-81. PubMed ID: 30908389
[TBL] [Abstract][Full Text] [Related]
5. Compliance With Fecal Calprotectin Testing in Pediatric Patients With Inflammatory Bowel Disease.
Queliza K; Wang MK; Kellermayer R
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):932-933. PubMed ID: 29135821
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of three stool calprotectin tests for home use.
Haisma SM; Galaurchi A; Almahwzi S; Adekanmi Balogun JA; Muller Kobold AC; van Rheenen PF
PLoS One; 2019; 14(4):e0214751. PubMed ID: 30998692
[TBL] [Abstract][Full Text] [Related]
8. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
Sidler MA; Leach ST; Day AS
Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
[TBL] [Abstract][Full Text] [Related]
9. Normative Fecal Calprotectin Concentrations in Guatemalan Preschoolers Are High Relative to Children Reported Elsewhere.
Soto-Méndez MJ; Romero-Abal ME; Schümann K; Gil Á; Solomons NW
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):238-244. PubMed ID: 27101538
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
Diamanti A; Colistro F; Basso MS; Papadatou B; Francalanci P; Bracci F; Muraca M; Knafelz D; De Angelis P; Castro M
Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
[TBL] [Abstract][Full Text] [Related]
11. Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
Vinding KK; Elsberg H; Thorkilgaard T; Belard E; Pedersen N; Elkjaer M; Marker D; Carlsen K; Burisch J; Munkholm P
Inflamm Bowel Dis; 2016 Feb; 22(2):336-44. PubMed ID: 26535869
[TBL] [Abstract][Full Text] [Related]
12. Patients' perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey.
Kalla R; Boyapati R; Vatn S; Hijos G; Crooks B; Moore GT; Hall V; Lipscomb G; Gomollón F; Jahnsen J; Singh S
Scand J Gastroenterol; 2018 Dec; 53(12):1437-1442. PubMed ID: 30451040
[TBL] [Abstract][Full Text] [Related]
13. Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients.
Bello C; Roseth A; Guardiola J; Reenaers C; Ruiz-Cerulla A; Van Kemseke C; Arajol C; Reinhard C; Seidel L; Louis E
Dig Liver Dis; 2017 Sep; 49(9):991-996. PubMed ID: 28587751
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases.
Inoue K; Aomatsu T; Yoden A; Okuhira T; Kaji E; Tamai H
J Gastroenterol Hepatol; 2014; 29(7):1406-12. PubMed ID: 24635100
[TBL] [Abstract][Full Text] [Related]
15. Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
Julsgaard M; Hvas CL; Gearry RB; Vestergaard T; Fallingborg J; Svenningsen L; Kjeldsen J; Sparrow MP; Wildt S; Kelsen J; Bell SJ
Inflamm Bowel Dis; 2017 Jul; 23(7):1240-1246. PubMed ID: 28498159
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.
Sipponen T; Kolho KL
Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558
[TBL] [Abstract][Full Text] [Related]
17. Validation of Two Calprotectin Rapid Tests in Daily Routine.
Schulz C; Wex T; Arnim UV; Malfertheiner P
Clin Lab; 2016 Jul; 62(7):1249-1254. PubMed ID: 28164652
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
19. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
[TBL] [Abstract][Full Text] [Related]
20. Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease.
Bressler B; Panaccione R; Fedorak RN; Seidman EG
Can J Gastroenterol Hepatol; 2015 Oct; 29(7):369-72. PubMed ID: 26125109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]